Ledger.Open graph →
SEC Form D · filed October 30, 2013

Koronis Pharma, Inc

Offering
$300K
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Donald J. Elmer · Seattle, WAExec · DirectorJean-Pierre Laurent · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗